TLJ 2.0 is a comprehensive experience that involves participants throughout the year and creates discussions that continue beyond the meeting.

The programme has been developed by ESOT’s Sections with the aim of providing value to all audiences. It features consensus workgroups, small mentoring sessions and keynote lectures, all connected seamlessly in an innovative approach.

The workgroups are at the core of TLJ 2.0 and they will develop a series of consensus papers aimed for publications in ESOT’s journal, Transplant International.


Topics of discussion have been selected based on an extensive consultation process among ESOT’s Sections & Committees. These topics are the focus of the workstreams, managed by leaders in the field, who will connect with peers and mentors. It is our goal to build an expanded network, trigger new research, collaboration, exchange and discussion.

The discussion starts in the workstreams and the outcomes are shared and presented at TLJ 2.0. 

WS01 – New Surrogate endpoints in transplantation

This consensus workshop will focus on endpoints solely on “how to define successful kidney transplantation”. This focuses on the innovative organ sources, like xenotransplants, 3D printed organs, lab grown organs, currently not used resuscitated organs using innovative perfusion techniques etc.

Led and moderated by Maarten Naesens and Stefan Schneeberger.

WS02 – CMV infection and disease

This workstream focuses on describing the state of the art of the prevention and treatment of CMV infection in solid organ transplant recipients.

Led by Paolo Antonio Grossi and moderated by Maria Simonenko and Cristina Rovelli.

Kindly supported by an unrestricted grant from MSD 

WS03 – Cancer in pre and post transplant patients

The aim of this workgroup is to establish a consensus on key questions concerning cancer in solid organ transplant recipients namely, what are the changes of immunosuppressive therapy that can currently be recommended in transplant recipients with skin and non-skin cancers.

Led by Umberto Maggiore and moderated by Ilaria Gandolfini and  Alessandra Palmisano.

WS04 – NRP after DCD

This workstream aims to provide an evidence based answer to the following question: Should NRP become standard of care in DCD donation?

Led by Ina Jochmans and moderated by
Maria Irene Bellini.

WS05 – It’s not only extended donor criteria, it’s extending the donor pool

Donation and transplantation is a going-on discipline. Organ donors and recipients are time by time more complex from the medical perspective and we must guarantee that the transplant of this non-standard and non extended criteria donor is safe.

Led by Giuseppe Feltrin and Nuria Masnou and moderated by Omar Taco.

WS06 – HLA desensitization

This workstream focuses on discussing the potential recipients with otherwise suitable donors who are relegated to the ever-expanding deceased-donor waiting list because of preformed human leukocyte antigen (HLA) antibodies (HLA sensitization) which may be acquired via pregnancy, transfusion, and/or prior transplant.

Led by Nizam Mamode and moderated by Edoardo Melilli.

Kindly supported by an unrestricted grant from HANSA

WS07 – COVID-19

Collaboration between members/countries of the ESOT community to analyse data retrospectively and to create a (flexible and regularly updated) guideline document to support the individuals (patients and clinicians) within the Transplant community in times of a pandemic.

Led by Vassilios Papalois and moderated by Maria Irene Bellini

Kindly supported by an unrestricted grant from MSD 

Learning Workstream

A full stream of mutual understanding and learning dedicated to Transplant Donor Coordinators, Allied Healthcare Professionals, Ethical, Legal and Psychosocial Aspects of Organ Transplantation and European Transplant Patient Organizations (ETPO).

Led by Anna Forsberg, Nichon Jansen, Hannah Maple, Emma Massey, David Paredes

SS01 (EKITA) – Combined Transplantation 

What are the main issues and considerations with regard to combined transplants from the surgical, medical and ethical point of view.

Led by Robert Langer

SS02 (ECTTA) – Heart and Lung

Biventricular heart failure (VADs and artificial hearts) and Ex Vivo Lung Perfusion (EVLP)

Led by Ivan Knezevic

SS03 (BSC-ECTORS-VCA) – New aspects in Organ Regeneration in Transplant Immunology 

Join the BSC symposium for the latest updates on regeneration, metabolism and innate immunity in transplantation research. We want to provide you with selected highlights and cutting edge innovations in transplant medicine with special regard to basic immunology, organ regeneration and vascularized composite tissue transplantation.

Led by Katja Kotsch